Zeist, 6 January 2022 – A group of over 65 leading institutional investors is calling on Covid-19 vaccine manufacturers to move quickly to increase the availability and deployment of vaccinations around the world. An Investor Statement has been drawn up to that end under the leadership of Achmea Investment Management. Letters have been sent to pharmaceutical companies asking them to make the global availability of vaccines part of the remuneration policy of managers and directors. In this way, investors want to hold them accountable for their contribution to solving this problem.
Institutional investors take action: vaccine equity no longer optional Zeist,
Jan 6th 2022